Vinge has advised Apotea AB (publ) (“Apotea”) in connection with its listing on Nasdaq Stockholm. Th…
On 11 October 2024, Strategic Value Partners, through Coniferous Bidco AB, announced a public takeov…
Vinge advises Cinclus Pharma Holding AB (publ) (“Cinclus Pharma”) in connection with an offering of…
Humana Group ("Humana") strengthens its offering of high-quality care services in Norway as Human Ca…
Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of…
Vinge has advised Vimian Group AB (publ) in connection with a partly guaranteed rights issue which w…
Stena Sessan AB has announced a recommended public offer to the shareholders of Concordia Maritime A…
Vinge has advised Cell Impact AB (publ) in connection with a partly guaranteed rights issue which wi…
Vinge has advised Thermo Fisher Scientific Inc., (”Thermo Fisher”), the world leader in serving scie…
Vinge advises Biotage AB (publ) (“Biotage”) in connection with its acquisition of Astrea Bioseparati…
Vinge advises Vimian in connection with a directed share issue of approximately MSEK 1,500, before i…
Vinge has advised VEF AB (publ) in connection with its list change from Nasdaq First North Growth Ma…
Vinge has advised the biopharmaceutical development company Cinclus Pharma in connection with a priv…
MGM Casino Next Lion, LLC has announced a recommended public offer to the shareholders of LeoVegas A…
Vinge has advised Titania Holding AB (publ) (“Titania”) in connection with its listing on Nasdaq Fir…
Vinge has advised Samhällsbyggnadsbolaget i Norden AB (”SBB”) in connection with a directed share is…
Vinge has advised Samhällsbyggnadsbolaget i Norden AB (”SBB”) in connection with the sale of propert…
Vinge has advised Flat Capital AB (publ) (“Flat Capital” or the “Company”) in connection with its li…
The share issue was carried out as an accelerated book building process and directed to selected Swe…
Vinge has advised VNV Ltd in connection with the process of changing the group’s domicile from Bermu…
